Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: Nanda who wrote (3206)	2/9/1998 2:10:00 PM
From: Gene Voss	Read Replies (1) \| Respond to of 3906

I'm here just have nothing to say.I did find out that their patent is not yet available for review.It is scheduled to be released 2/17 as stated by the company.The contents are known only by HVSFD.The statements that they will receive approval for the transurethral application of meds to treat ED are in my experience incorrect.This is data in the public domain so it cannot be patented twice.They will receive some sort of protection but the significance is subject to question. GV